India's Ayush promotion via trade deals faces significant international market barriers. Regulatory, clinical-trial, and data gaps impede product approval, with issues like lack of Ayurveda recognition, poly-herbal formulation registration, and heavy metal limits. Limited research and patents further complicate expansion. The author recommends nodal regulators, detailed market studies, and industry-ministry partnerships. While trade pacts open doors, systematic action and evidence-based support are crucial for global Ayush recognition. These steps are vital for expanding Ayush's outreach and solidifying its status worldwide.